Non-small cell lung cancer
Conditions
Interventions
Adding or not adding a cfRNA protection fluid groups:None
Sponsors
Beijing Hospital, National Center of Gerontology
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Signed informed consent, age > 18 and < 90 years old; (2) Patients with NSCLC who are pathologically confirmed to have NSCLC with any stage according to the 9th edition TNM of the International Association for the Study of Lung Cancer; (3) Provide clinical and pathological data required for research during the treatment process, and agree to use the test data for subsequent research and product development
Exclusion criteria
Exclusion criteria: (1) suffering from other malignant tumors or severe multiple organ dysfunction; (2) It is not appropriate to accept CNB after assessment; (3) The tissue samples obtained by CNB did not meet the requirements for tumor driver gene detection; (4) any other conditions that the study physician considers inappropriate for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cfDNA&cfRNA concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Threshold CT values for cfRNAs;The effectiveness of the cfRNA protection solution;Concordance rate of RNA-related gene testing; | — |
Countries
China
Contacts
Public ContactXiao-Guang Li
Beijing Hospital, National Center of Gerontology
Outcome results
None listed